HX‐1171, a Novel Nrf2 Activator, Induces <i>NQO1</i> and <i>HMOX1</i> Expression

Jimin Kim, Jimin Kim, Su‐Hyun Shin, Young‐Eun Ko, Tokutaro Miki, Heung‐Mo Bae, Jong‐Koo Kang, Jae Wha Kim, Jae Wha Kim

Journal of Cellular Biochemistry · 2017 · 11 citations · 33 references

Concepts

Abstract

HX-1171 (1-O-hexyl-2,3,5-trimethylhydroquinone) is a novel synthesized vitamin E derivative, which reportedly has positive effects on various diseases and conditions, such as liver fibrosis, hepatic cirrhosis, and cancer. In this study, we analyzed the transcriptional activity induced by HX-1171. Results from reverse transcription polymerase chain reaction and promoter assays reveal that HX-1171 increased the expression of NQO1 and HMOX1, encoding antioxidant-related enzymes, in A549 human lung epithelial cells. The activity of nuclear factor-E2-related factor (Nrf2), a key transcriptional factor for antioxidative enzymes, was examined in HX-1171-treated cells. Confocal microscopy and Western blotting showed that HX-1171 effectively induced the nuclear translocation and transcriptional activity of Nrf2. We conclude that HX-1171, a novel Nrf2 activator, may be a promising therapeutic agent for oxidative stress-induced diseases. J. Cell. Biochem. 118: 3372-3380, 2017. © 2017 Wiley Periodicals, Inc.

References

33